Nektar Therapeutics (LON:0UNL)
London · Delayed Price · Currency is GBP · Price in USD 68.09
+2.28 (3.46%)
Feb 12, 2026, 5:10 PM GMT
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of 1.06 billion as of February 12, 2026. Its market cap has increased by 750.95% in one year.
Market Cap
1.06B
Enterprise Value
984.52M
Revenue
46.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
68.09
Market Cap Chart
Since May 3, 1994, Nektar Therapeutics's market cap has increased from 42.81M to 1.06B, an increase of 2,376.36%. That is a compound annual growth rate of 10.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 989.20M | 54.80% |
| Dec 31, 2025 | 639.01M | 366.34% |
| Dec 31, 2024 | 137.03M | 61.93% |
| Dec 29, 2023 | 84.62M | -76.00% |
| Dec 30, 2022 | 352.54M | -80.85% |
| Dec 31, 2021 | 1.84B | -17.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.82B |
| Oxford Nanopore Technologies | 1.40B |
| Oxford Biomedica | 1.00B |
| CVS Group | 958.33M |
| Spire Healthcare Group | 814.80M |